Suppr超能文献

如何评估自身免疫性血细胞减少症患者的免疫缺陷:与免疫失调相关的先天性免疫缺陷的诊断的实验室评估。

How to evaluate for immunodeficiency in patients with autoimmune cytopenias: laboratory evaluation for the diagnosis of inborn errors of immunity associated with immune dysregulation.

机构信息

Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH.

出版信息

Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):661-672. doi: 10.1182/hematology.2020000173.

Abstract

The identification of genetic disorders associated with dysregulated immunity has upended the notion that germline pathogenic variants in immune genes universally result in susceptibility to infection. Immune dysregulation (autoimmunity, autoinflammation, lymphoproliferation, and malignancy) and immunodeficiency (susceptibility to infection) represent 2 sides of the same coin and are not mutually exclusive. Also, although autoimmunity implies dysregulation within the adaptive immune system and autoinflammation indicates disordered innate immunity, these lines may be blurred, depending on the genetic defect and diversity in clinical and immunological phenotypes. Patients with immune dysregulatory disorders may present to a variety of clinical specialties, depending on the dominant clinical features. Therefore, awareness of these disorders, which may manifest at any age, is essential to avoid a protracted diagnostic evaluation and associated complications. Availability of and access to expanded immunological testing has altered the diagnostic landscape for immunological diseases. Nonetheless, there are constraints in using these resources due to a lack of awareness, challenges in systematic and logical evaluation, interpretation of results, and using results to justify additional advanced testing, when needed. The ability to molecularly characterize immune defects and develop "bespoke" therapy and management mandates a new paradigm for diagnostic evaluation of these patients. The immunological tests run the gamut from triage to confirmation and can be used for both diagnosis and refinement of treatment or management strategies. However, the complexity of testing and interpretation of results often necessitates dialogue between laboratory immunologists and specialty physicians to ensure timely and appropriate use of testing and delivery of care.

摘要

与免疫失调相关的遗传疾病的鉴定颠覆了这样一种观念,即免疫基因中的种系致病性变异普遍导致易感染。免疫失调(自身免疫、自身炎症、淋巴增生和恶性肿瘤)和免疫缺陷(易感染)代表同一枚硬币的两面,并非相互排斥。此外,尽管自身免疫意味着适应性免疫系统的失调,自身炎症表明固有免疫失调,但这些界限可能因遗传缺陷和临床及免疫学表型的多样性而变得模糊。由于临床表现的多样性,免疫调节紊乱患者可能会到多个临床科室就诊。因此,认识这些可能在任何年龄出现的疾病对于避免冗长的诊断评估和相关并发症至关重要。扩展的免疫学检测的可用性和可及性改变了免疫性疾病的诊断格局。尽管如此,由于缺乏认识、系统和逻辑评估、结果解释方面的挑战,以及在需要时使用结果来证明额外的高级检测的合理性,在利用这些资源方面存在限制。对免疫缺陷进行分子特征分析并开发“定制”疗法和管理方案,这就要求对这些患者进行诊断评估的新范式。免疫检测的范围从分诊到确诊,可用于诊断和完善治疗或管理策略。然而,检测的复杂性和结果的解释通常需要实验室免疫学家和专科医生之间的对话,以确保及时和适当的使用检测并提供护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7719/7727558/b7d444d13b00/bloodbook-2020-661-absf1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验